[ET Net News Agency, 30 May 2022] Credit Suisse lowered its target price for Ali Health
(00241) to HK$6 from HK$8 and maintained its "outperform" rating.
The research house said it reduces FY23/24E net loss by 40%/63%, mainly due to increased
gross margin and lower cost ratios. (RC)